The Swedish Society of Medicine   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Switzerland (1808)

Organization Overview

First Clinical Trial
2009
NCT03551080
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

The Swedish Society of Medicine

Active Ingredients

Drugs in Phase 3 Trials (1)

melatonin (1 trial)

Drugs in Phase 1 Trials (2)

l-nmma (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (2)

endotoxin (1 trial)

lipopolysaccharide (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5